PharmTech News

Articles

On the last day of CPhI Worldwide (Thursday Nov. 7, 2019), several experts will examine the potential role of three-dimensional printing within medicines, particularly in light of the shift in the industry from volume to value.

The Future Role of 3D Printing in Personalized Medicines

Avantor’s Senior Vice-President of Business Development and Commercial Operations (Claudia Berrón) will be presenting trends in raw material data mining and sharing within biopharma on the last afternoon of CPhI Worldwide (Thursday Nov. 7, 2019).

Data Mining and Sharing to Reduce Costs and Improve Productivity

On Wednesday Nov. 6, 2019, Dr. Derek Duncan from Lighthouse Instruments will summarize the current state of container closure integrity testing (CCIT) in the bio/pharma industry and will outline a framework for the development of a holistic testing strategy.



Maintaining Sterility and Stability of Injectables

Contract development and manufacturing organization (CDMO), Sterling Pharma Solutions, has revealed its investment of $1.5 million into a phased expansion of its facility based in North Carolina, United States.


Sterling Pharma Solutions Invests into US Expansion

A number of experts will be examining investment opportunities within the evolving cell and gene therapy sector, in a panel discussion on Wednesday morning (Nov. 6, 2019) during CPhI Worldwide in Frankfurt, Germany.

Investing in Cell and Gene Technology

The second part of CPhI’s annual report has projected that the biologic manufacturing capacity of Europe will exceed that of the United States by 2023, as a result of the rising number of commercially approved biologics.


Europe’s Biologic Manufacturing Capacity Shows Potential, According to CPhI Report

According to the third part of the CPhI annual report, a lack of cell and gene expertise may be a drag factor on the sector and a spike in biological therapeutics development is driving bio demand in China.


CPhI Report Predicts Cell and Gene Expertise Shortfall and Growth in China Bio

The new Javené, France-based facility is expected to increase the company’s production capacity of injectable grade sodium hyaluronate obtained by fermentation by 2.5 times.

HTL to Invest in Production Facility for Injectable Grade Sodium Hyaluronate

Ashland will be presenting new devices at booth 102B13 at CPhI Worldwide. 

Ashland to Present New Pharma Solutions at CPhI Worldwide 2019

Dr. Ger Brophy, executive vice president, Biopharma Production for Avantor, will deliver the keynote address at the conference and Claudia Berrón, senior vice president, Business Development and Commercial Operations for Avantor, will discuss on leveraging biopharma 4.0 to reconstruct the biopharma supply chain and manufacturing practices.

CPhI News